287 related articles for article (PubMed ID: 8751936)
1. NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
Tine JA; Lanar DE; Smith DM; Wellde BT; Schultheiss P; Ware LA; Kauffman EB; Wirtz RA; De Taisne C; Hui GS; Chang SP; Church P; Hollingdale MR; Kaslow DC; Hoffman S; Guito KP; Ballou WR; Sadoff JC; Paoletti E
Infect Immun; 1996 Sep; 64(9):3833-44. PubMed ID: 8751936
[TBL] [Abstract][Full Text] [Related]
2. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
Ockenhouse CF; Sun PF; Lanar DE; Wellde BT; Hall BT; Kester K; Stoute JA; Magill A; Krzych U; Farley L; Wirtz RA; Sadoff JC; Kaslow DC; Kumar S; Church LW; Crutcher JM; Wizel B; Hoffman S; Lalvani A; Hill AV; Tine JA; Guito KP; de Taisne C; Anders R; Ballou WR
J Infect Dis; 1998 Jun; 177(6):1664-73. PubMed ID: 9607847
[TBL] [Abstract][Full Text] [Related]
3. Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
Biswas S; Spencer AJ; Forbes EK; Gilbert SC; Holder AA; Hill AV; Draper SJ
J Immunol; 2012 May; 188(10):5041-53. PubMed ID: 22504652
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
5. Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen.
Rogers WO; Weiss WR; Kumar A; Aguiar JC; Tine JA; Gwadz R; Harre JG; Gowda K; Rathore D; Kumar S; Hoffman SL
Infect Immun; 2002 Aug; 70(8):4329-35. PubMed ID: 12117942
[TBL] [Abstract][Full Text] [Related]
6. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
Bettencourt P
Front Immunol; 2020; 11():190. PubMed ID: 32153565
[No Abstract] [Full Text] [Related]
7. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.
Kocken CH; Withers-Martinez C; Dubbeld MA; van der Wel A; Hackett F; Valderrama A; Blackman MJ; Thomas AW
Infect Immun; 2002 Aug; 70(8):4471-6. PubMed ID: 12117958
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
9. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
[TBL] [Abstract][Full Text] [Related]
10. A direct and rapid sequencing strategy for the Plasmodium falciparum antigen gene gp190/MSA1.
Pan W; Tolle R; Bujard H
Mol Biochem Parasitol; 1995 Jul; 73(1-2):241-4. PubMed ID: 8577332
[No Abstract] [Full Text] [Related]
11. Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.
Iyori M; Nakaya H; Inagaki K; Pichyangkul S; Yamamoto DS; Kawasaki M; Kwak K; Mizukoshi M; Goto Y; Matsuoka H; Matsumoto M; Yoshida S
PLoS One; 2013; 8(8):e70819. PubMed ID: 23951015
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a vaccinia virus vectored multi-epitope live vaccine candidate for Plasmodium falciparum.
Dong W; Li M; Bi H; Li Y; Wu J; Qu L
Int J Parasitol; 2001 Jan; 31(1):57-62. PubMed ID: 11165271
[TBL] [Abstract][Full Text] [Related]
13. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
[TBL] [Abstract][Full Text] [Related]
14. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
[TBL] [Abstract][Full Text] [Related]
15. Development, expression, and murine testing of a multistage Plasmodium falciparum malaria vaccine candidate.
Shi YP; Das P; Holloway B; Udhayakumar V; Tongren JE; Candal F; Biswas S; Ahmad R; Hasnain SE; Lal AA
Vaccine; 2000 Jun; 18(25):2902-14. PubMed ID: 10812234
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum.
Teo WH; Nurul AA; Norazmi MN
Trop Biomed; 2012 Jun; 29(2):239-53. PubMed ID: 22735846
[TBL] [Abstract][Full Text] [Related]
19. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
Saul A
J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
[No Abstract] [Full Text] [Related]
20. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.
Trieu A; Kayala MA; Burk C; Molina DM; Freilich DA; Richie TL; Baldi P; Felgner PL; Doolan DL
Mol Cell Proteomics; 2011 Sep; 10(9):M111.007948. PubMed ID: 21628511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
